Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Du S, et al
Other meaningful insights include: Patient characteristics associated with early uptake Height and weight, enabling calculation of exact BMI, which is critically relevant for this market Clinician-documented attributes relevant to treatment selection, such as other vitals, lifestyle factors, social determinants of health, and other GLP-1 decision drivers HCP prescribing behavior, including identification of early adopters Source of business Differentiation between new-to-therapy patients and switchers Rich insights like thesecaptured early are necessary to understand who is being treated, why specific therapies are chosen, and whether early adoption reflects substitution within the category or expansion of the treated population
A more strategic clinical decision is to maintain the GLP-1 at a tolerable maintenance dose to control appetite, and introduce a complementary mechanism
For readers comparing pasteurized vs lyophilized probiotic formats, the key consideration is how each formulation relates to stability, microbial viability, delivery quality, safety, and the intended microbiome-support mechanism
The semaglutide to tirzepatide conversion chart provides additional switching context if you are coming from a different GLP-1 medication first, and understanding compounded tirzepatide starting doses is important when beginning the new regimen
